- Home
- CRIS vs DUKR Comparison
CRIS vs DUKR Comparison
Compare CRIS & DUKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.63
N/A
Current Price
$5.18
Company Overview
Basic Information| Metric | CRIS | DUKR |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 20.1M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRIS | DUKR |
|---|---|---|
| Price | $4.63 | $5.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 7.6M | 29.4K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.57 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,898,000.00 | N/A |
| Revenue This Year | $27.10 | N/A |
| Revenue Next Year | $67.74 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.18 | $4.75 |
| 52 Week High | $6.74 | $7.41 |
Technical Indicators
Market Signals| Indicator | CRIS | DUKR |
|---|---|---|
| Relative Strength Index (RSI) | 73.85 | 30.26 |
| Support Level | $0.75 | $4.91 |
| Resistance Level | $6.74 | $5.78 |
| Average True Range (ATR) | 0.44 | 0.64 |
| MACD | 0.30 | -0.00 |
| Stochastic Oscillator | 66.77 | 15.48 |
Price Performance
Historical Comparison CRIS
DUKR
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.